NEELIMA NALLURI: Open Payments
NPI 1134862550 · COTTLEVILLE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,074 in 39 payments from 17 companies in 2025. Trend: 2023 $713 · 2024 $606 · 2025 $1,074
Food & beverage: $1,074
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $213 |
| Kestra Medical Technology Services, Inc. | 9 | $155 |
| Novartis Pharmaceuticals Corporation | 1 | $89 |
| CVRx, Inc. | 1 | $81 |
| E.R. Squibb & Sons, L.L.C. | 4 | $80 |
| Cleerly, Inc. | 1 | $70 |
| Novo Nordisk Inc | 3 | $63 |
| Corcept Therapeutics | 2 | $52 |
| Merck Sharp & Dohme LLC | 3 | $46 |
| Esperion Therapeutics, Inc. | 2 | $40 |
Products named: Kerendia, Assure WCD, LEQVIO, Barostim Neo System, Cleerly Ischemia, Korlym, Wegovy, VERQUVO.
Industry payments across MO — which companies pay providers there.
